LataMed AI Corp. (OTC: LMED), a healthcare technology company focused on digital health and artificial intelligence solutions for Latin America, announced today that its Venezuelan subsidiary, LATAMEDAI VE, has signed an agreement with the Venezuelan Institute for Scientific Research (IVIC) to develop a digital platform module. This module is designed to facilitate access to designated laboratory and scientific services, a move that could broaden the company's reach beyond patient-facing telemedicine.
Under the agreement, LataMed AI and IVIC will collaborate on the design, development, testing, and implementation of a digital interface. This interface will allow authorized business and institutional users to request available laboratory services, schedule appointments, monitor the status of submitted requests, access approved reports and documentation, and complete authorized payment-related processes. The proposed module aims to provide a centralized digital workflow for organizations in sectors such as healthcare, pharmaceuticals, food production, agriculture, and related industries. The specific services made available will be determined by IVIC and implemented according to technical, operational, security, and legal requirements established by both parties.
LataMed AI will initiate work with IVIC to define the module's functional requirements, user-access procedures, data architecture, payment workflows, document-management capabilities, and a phased testing and implementation process. The parties will also establish procedures governing the handling, transmission, storage, and authorized access to laboratory-related information and documentation. The platform's potential functionality includes electronic service requests, appointment scheduling, request-status tracking, secure payment facilitation, and controlled access to laboratory reports or other authorized documentation. The final functionality, implementation schedule, and scope of services remain subject to continued technical development, testing, and approval.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated, "This agreement represents an opportunity to apply our technology to an important area of scientific and enterprise service delivery. Our objective is to work with IVIC to develop a responsible digital framework that makes it easier for authorized users to request services, manage appointments, monitor processes, and access approved information through a centralized platform."
Management believes this initiative could expand LataMed AI's capabilities beyond telemedicine by demonstrating how its technology supports institutional and enterprise workflows involving healthcare, scientific services, laboratory coordination, and digital documentation. The project aligns with the company's broader strategy of developing digital infrastructure that connects patients, healthcare professionals, pharmacies, insurers, payment providers, wellness organizations, institutions, and other participants in the healthcare and scientific-services ecosystem.
If successfully implemented, the module could potentially be adapted for other institutional and enterprise service environments in Venezuela and elsewhere in Latin America. However, any future expansion would depend on separate agreements, technical readiness, regulatory requirements, and the needs of participating institutions. The agreement establishes a framework for development and evaluation, but it does not guarantee a specific implementation date, user adoption level, service volume, revenue, profitability, or expansion to additional institutions.
The company will provide further updates as development, testing, and implementation progress. For additional information, interested parties can visit https://latamed.ai or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
